Cargando…

Adverse cutaneous drug reactions: Eight year assessment in hospitalized patients

BACKGROUND: Adverse cutaneous drug reactions (ACDRs) are the most commonly reported adverse drug events. The causative drugs and clinical patterns of ACDRs are different in various populations. This study was conducted to identify the clinical patterns, causative drugs and reasons for drug administr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mokhtari, Fatemeh, Nikyar, Zahra, Naeini, Bahareh Abtahi, Esfahani, Alireza Asemi, Rahmani, Siamak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235091/
https://www.ncbi.nlm.nih.gov/pubmed/25422656
_version_ 1782344965325586432
author Mokhtari, Fatemeh
Nikyar, Zahra
Naeini, Bahareh Abtahi
Esfahani, Alireza Asemi
Rahmani, Siamak
author_facet Mokhtari, Fatemeh
Nikyar, Zahra
Naeini, Bahareh Abtahi
Esfahani, Alireza Asemi
Rahmani, Siamak
author_sort Mokhtari, Fatemeh
collection PubMed
description BACKGROUND: Adverse cutaneous drug reactions (ACDRs) are the most commonly reported adverse drug events. The causative drugs and clinical patterns of ACDRs are different in various populations. This study was conducted to identify the clinical patterns, causative drugs and reasons for drug administration in patients hospitalized due to ACDR. MATERIALS AND METHODS: This retrospective study was carried out in a referral university hospital, Isfahan, Iran. The medical records of all patients who were hospitalized in the Dermatology Department due to ACDRs were reviewed covering an 8-year period between December 2006 and August 2013. RESULTS: A total number of 282 patients with the mean age of 29.48 ± 21.18 years were hospitalized in this time period, of which 61% were females. The most common clinical patterns regarding the final diagnosis were Stevens-Johnson syndrome (SJS) (32%), exanthematous drug eruptions (24.5%) and toxic epidermal necrolysis (TEN) (11%). Anticonvulsants were the most frequently implicated drug group (51.8%) followed by antibiotics (33.7%) and analgesics and non-steroidal anti-inflammatory drugs (5.7%). The most common cause of drug administration was seizure (30%) and then upper respiratory tract infections (12%). The frequency distribution of clinical types of reactions was different between age groups (P < 0.001). The severe types (SJS, TEN, drug rash with eosinophilia and systemic symptoms and overlap syndrome) were more frequent in the patients aged ≤50 years old (55.2%) compare to those aged ≤50 years (28%) (P = 0.001). CONCLUSION: The main causative drugs of ACDRs were anticonvulsants and antibiotics. However, the sever types of reactions were more prevalent.
format Online
Article
Text
id pubmed-4235091
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-42350912014-11-24 Adverse cutaneous drug reactions: Eight year assessment in hospitalized patients Mokhtari, Fatemeh Nikyar, Zahra Naeini, Bahareh Abtahi Esfahani, Alireza Asemi Rahmani, Siamak J Res Med Sci Original Article BACKGROUND: Adverse cutaneous drug reactions (ACDRs) are the most commonly reported adverse drug events. The causative drugs and clinical patterns of ACDRs are different in various populations. This study was conducted to identify the clinical patterns, causative drugs and reasons for drug administration in patients hospitalized due to ACDR. MATERIALS AND METHODS: This retrospective study was carried out in a referral university hospital, Isfahan, Iran. The medical records of all patients who were hospitalized in the Dermatology Department due to ACDRs were reviewed covering an 8-year period between December 2006 and August 2013. RESULTS: A total number of 282 patients with the mean age of 29.48 ± 21.18 years were hospitalized in this time period, of which 61% were females. The most common clinical patterns regarding the final diagnosis were Stevens-Johnson syndrome (SJS) (32%), exanthematous drug eruptions (24.5%) and toxic epidermal necrolysis (TEN) (11%). Anticonvulsants were the most frequently implicated drug group (51.8%) followed by antibiotics (33.7%) and analgesics and non-steroidal anti-inflammatory drugs (5.7%). The most common cause of drug administration was seizure (30%) and then upper respiratory tract infections (12%). The frequency distribution of clinical types of reactions was different between age groups (P < 0.001). The severe types (SJS, TEN, drug rash with eosinophilia and systemic symptoms and overlap syndrome) were more frequent in the patients aged ≤50 years old (55.2%) compare to those aged ≤50 years (28%) (P = 0.001). CONCLUSION: The main causative drugs of ACDRs were anticonvulsants and antibiotics. However, the sever types of reactions were more prevalent. Medknow Publications & Media Pvt Ltd 2014-08 /pmc/articles/PMC4235091/ /pubmed/25422656 Text en Copyright: © Journal of Research in Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Mokhtari, Fatemeh
Nikyar, Zahra
Naeini, Bahareh Abtahi
Esfahani, Alireza Asemi
Rahmani, Siamak
Adverse cutaneous drug reactions: Eight year assessment in hospitalized patients
title Adverse cutaneous drug reactions: Eight year assessment in hospitalized patients
title_full Adverse cutaneous drug reactions: Eight year assessment in hospitalized patients
title_fullStr Adverse cutaneous drug reactions: Eight year assessment in hospitalized patients
title_full_unstemmed Adverse cutaneous drug reactions: Eight year assessment in hospitalized patients
title_short Adverse cutaneous drug reactions: Eight year assessment in hospitalized patients
title_sort adverse cutaneous drug reactions: eight year assessment in hospitalized patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235091/
https://www.ncbi.nlm.nih.gov/pubmed/25422656
work_keys_str_mv AT mokhtarifatemeh adversecutaneousdrugreactionseightyearassessmentinhospitalizedpatients
AT nikyarzahra adversecutaneousdrugreactionseightyearassessmentinhospitalizedpatients
AT naeinibaharehabtahi adversecutaneousdrugreactionseightyearassessmentinhospitalizedpatients
AT esfahanialirezaasemi adversecutaneousdrugreactionseightyearassessmentinhospitalizedpatients
AT rahmanisiamak adversecutaneousdrugreactionseightyearassessmentinhospitalizedpatients